National Repository of Dissertations in Serbia
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrilic)
    • Serbian (Latin)
  • Login
View Item 
  •   NaRDuS home
  • Универзитет у Нишу
  • Медицински факултет
  • View Item
  •   NaRDuS home
  • Универзитет у Нишу
  • Медицински факултет
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Prediktivni značaj biomarkera bcl2, bcl6, CD10 i MUM1 kod difuznih B krupnoćelijskih limfoma

Thumbnail
2015
Disertacija629.pdf (5.782Mb)
Petkovic_Ivan_Z.pdf (544.2Kb)
Author
Petković, Ivan Z.
Mentor
Vrbić, Svetislav
Committee members
Pejčić, Ivica
Filipović, Slađana
Tukić, Ljiljana
Krstić, Miljan
Metadata
Show full item record
Abstract
INTRODUCTION: Patients with diffuse large B-cell lymphoma (DLBCL) have heterogenous clinical course and prognosis. There is a continuing need for the development of contemporary predictive models for the stratification of patients. Immunohistochemical biomarkers in correlation with clinical and biochemical parametres can offer such predictive models for patient stratification. AIM: The main objective of this study was to examine the predictive value of immnohistochemical biomarkers expression (bcl2, bcl6, CD10 and MUM1), according to Hans and Muris algorithm and subclassification of Hans algorithm) with biochemical, clinical and score/index characteristics in the studied patient population in order to define their impact on the response to therapy, the risk of death and duration of progression free survival (PFS). METHODS: The techinique of classical semiquantitative immunohistochemical analysis for the biomarkers expression were used. All analyzed data were collected from medical do...cumentation The statistical methods included the use of non-parametric tests (x2-test, Mann-Whitney U test, Kruskal-Wallis tests and others) as well the use of parametric tests if the characteristics were numeric and distribution normal (Student’s t-test, ANOVA). PFS was examined by Kaplan-Meier analysis. The univariate, and multivariate analysis of risk factors for response to therapy and duration of PFS were assessed. IMPORTANCE: The original contributions of this study are reflected in the confirmation of Muris’s score, as well as bcl2 biomarker and IPI score as parametres that have predictive value in the risk stratification of patients into prognostic categories in the rituximab era. This findings can be applied in real clinical practice. For the first time a correlation of NCCN-IPI score and bcl6 biomarker has been established in the prediction of therapeutic response. It was found that male gender was associated with an increased mortality risk in DLBCL patients.

Faculty:
University of Niš, Faculty of Medicine
Date:
10-07-2015
Keywords:
DLBCL / DLBCL / bcl2 / bcl6 / CD10 / MUM1 / biomarkeri / prediktivni značaj / bcl2 / bcl6 / CD10 / MUM1 / biomarkers / predictive value
[ Google Scholar ]
URI
http://eteze.ni.ac.rs/application/showtheses?thesesId=2594
http://nardus.mpn.gov.rs/handle/123456789/4997
https://fedorani.ni.ac.rs/fedora/get/o:1036/bdef:Content/download
http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70052&RID=1025319917

DSpace software copyright © 2002-2015  DuraSpace
About NaRDus | Contact us

OpenAIRERCUBRODOSTEMPUS
 

 

Browse

All of DSpaceUniversities & FacultiesAuthorsMentorCommittee membersSubjectsThis CollectionAuthorsMentorCommittee membersSubjects

DSpace software copyright © 2002-2015  DuraSpace
About NaRDus | Contact us

OpenAIRERCUBRODOSTEMPUS